Malonyl coenzyme a decarboxylase deficiency: Early dietary restriction and time course of cardiomyopathy

Carlos E. Prada, John Jefferies, Michelle A. Grenier, Christina M. Huth, Kimberley I. Page, Robert L. Spicer, Jeffrey Towbin, Nancy D. Leslie

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Malonyl coenzyme A (CoA) decarboxylase (MCD) deficiency is a rare autosomal recessive organic acidemia characterized by varying degrees of organ involvement and severity. MCD regulates fatty acid biosynthesis and converts malonyl-CoA to acetyl-CoA. Cardiomyopathy is 1 of the leading causes of morbidity and mortality in this disorder. It is unknown if diet alone prevents cardiomyopathy development based in published literature. We report a 10-month-old infant girl identified by newborn screening and confirmed MCD deficiency with a novel homozygous MLYCD mutation. She had normal echocardiogram measurements before transition to high medium-chain triglycerides and low long-chain triglycerides diet. Left ventricular noncompaction development was not prevented by dietary interventions. Further restriction of long-chain triglycerides and medium-chain triglycerides supplementation in combination with angiotensin-converting enzyme inhibitors helped to improve echocardiogram findings. Patient remained asymptomatic, with normal development and growth. Our case emphasizes the need for ongoing cardiac disease screening in patients with MCD deficiency and the benefits and limitations of current dietary interventions.

Original languageEnglish (US)
JournalPediatrics
Volume130
Issue number2
DOIs
StatePublished - Aug 1 2012

Fingerprint

Carboxy-Lyases
Coenzymes
Cardiomyopathies
Triglycerides
Malonyl Coenzyme A
Diet
Acetyl Coenzyme A
Growth and Development
Angiotensin-Converting Enzyme Inhibitors
Heart Diseases
Fatty Acids
Newborn Infant
Morbidity
Mutation
Mortality

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Malonyl coenzyme a decarboxylase deficiency : Early dietary restriction and time course of cardiomyopathy. / Prada, Carlos E.; Jefferies, John; Grenier, Michelle A.; Huth, Christina M.; Page, Kimberley I.; Spicer, Robert L.; Towbin, Jeffrey; Leslie, Nancy D.

In: Pediatrics, Vol. 130, No. 2, 01.08.2012.

Research output: Contribution to journalArticle

Prada, Carlos E. ; Jefferies, John ; Grenier, Michelle A. ; Huth, Christina M. ; Page, Kimberley I. ; Spicer, Robert L. ; Towbin, Jeffrey ; Leslie, Nancy D. / Malonyl coenzyme a decarboxylase deficiency : Early dietary restriction and time course of cardiomyopathy. In: Pediatrics. 2012 ; Vol. 130, No. 2.
@article{e082a8ac36fc4f8eac3e817ab04d36fb,
title = "Malonyl coenzyme a decarboxylase deficiency: Early dietary restriction and time course of cardiomyopathy",
abstract = "Malonyl coenzyme A (CoA) decarboxylase (MCD) deficiency is a rare autosomal recessive organic acidemia characterized by varying degrees of organ involvement and severity. MCD regulates fatty acid biosynthesis and converts malonyl-CoA to acetyl-CoA. Cardiomyopathy is 1 of the leading causes of morbidity and mortality in this disorder. It is unknown if diet alone prevents cardiomyopathy development based in published literature. We report a 10-month-old infant girl identified by newborn screening and confirmed MCD deficiency with a novel homozygous MLYCD mutation. She had normal echocardiogram measurements before transition to high medium-chain triglycerides and low long-chain triglycerides diet. Left ventricular noncompaction development was not prevented by dietary interventions. Further restriction of long-chain triglycerides and medium-chain triglycerides supplementation in combination with angiotensin-converting enzyme inhibitors helped to improve echocardiogram findings. Patient remained asymptomatic, with normal development and growth. Our case emphasizes the need for ongoing cardiac disease screening in patients with MCD deficiency and the benefits and limitations of current dietary interventions.",
author = "Prada, {Carlos E.} and John Jefferies and Grenier, {Michelle A.} and Huth, {Christina M.} and Page, {Kimberley I.} and Spicer, {Robert L.} and Jeffrey Towbin and Leslie, {Nancy D.}",
year = "2012",
month = "8",
day = "1",
doi = "10.1542/peds.2011-2927",
language = "English (US)",
volume = "130",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2",

}

TY - JOUR

T1 - Malonyl coenzyme a decarboxylase deficiency

T2 - Early dietary restriction and time course of cardiomyopathy

AU - Prada, Carlos E.

AU - Jefferies, John

AU - Grenier, Michelle A.

AU - Huth, Christina M.

AU - Page, Kimberley I.

AU - Spicer, Robert L.

AU - Towbin, Jeffrey

AU - Leslie, Nancy D.

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Malonyl coenzyme A (CoA) decarboxylase (MCD) deficiency is a rare autosomal recessive organic acidemia characterized by varying degrees of organ involvement and severity. MCD regulates fatty acid biosynthesis and converts malonyl-CoA to acetyl-CoA. Cardiomyopathy is 1 of the leading causes of morbidity and mortality in this disorder. It is unknown if diet alone prevents cardiomyopathy development based in published literature. We report a 10-month-old infant girl identified by newborn screening and confirmed MCD deficiency with a novel homozygous MLYCD mutation. She had normal echocardiogram measurements before transition to high medium-chain triglycerides and low long-chain triglycerides diet. Left ventricular noncompaction development was not prevented by dietary interventions. Further restriction of long-chain triglycerides and medium-chain triglycerides supplementation in combination with angiotensin-converting enzyme inhibitors helped to improve echocardiogram findings. Patient remained asymptomatic, with normal development and growth. Our case emphasizes the need for ongoing cardiac disease screening in patients with MCD deficiency and the benefits and limitations of current dietary interventions.

AB - Malonyl coenzyme A (CoA) decarboxylase (MCD) deficiency is a rare autosomal recessive organic acidemia characterized by varying degrees of organ involvement and severity. MCD regulates fatty acid biosynthesis and converts malonyl-CoA to acetyl-CoA. Cardiomyopathy is 1 of the leading causes of morbidity and mortality in this disorder. It is unknown if diet alone prevents cardiomyopathy development based in published literature. We report a 10-month-old infant girl identified by newborn screening and confirmed MCD deficiency with a novel homozygous MLYCD mutation. She had normal echocardiogram measurements before transition to high medium-chain triglycerides and low long-chain triglycerides diet. Left ventricular noncompaction development was not prevented by dietary interventions. Further restriction of long-chain triglycerides and medium-chain triglycerides supplementation in combination with angiotensin-converting enzyme inhibitors helped to improve echocardiogram findings. Patient remained asymptomatic, with normal development and growth. Our case emphasizes the need for ongoing cardiac disease screening in patients with MCD deficiency and the benefits and limitations of current dietary interventions.

UR - http://www.scopus.com/inward/record.url?scp=84864515189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864515189&partnerID=8YFLogxK

U2 - 10.1542/peds.2011-2927

DO - 10.1542/peds.2011-2927

M3 - Article

C2 - 22778304

AN - SCOPUS:84864515189

VL - 130

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2

ER -